[1]
|
Carroll, N.V., Miederhoff, P.A. and Waters, L.W. (1996) Profitability, Third-Party Reimbursement, and Access to Community Pharmacies. Clinical Therapeutics, 118, 703-715. http://dx.doi.org/10.1016/S0149-2918(96)80221-9
|
[2]
|
Anon (2005) Trend of the Month: Pharmacy Reimbursement Continues to Drop. Drug Benefit Trends, 17, 8.
|
[3]
|
NACDS Statement on Medicaid Prescription Drugs: Examining Options for Payment Reform. Presented to the Hearing of the House Energy and Commerce Committee Subcommittee on Health, 2005.
|
[4]
|
Willink, D.P. and Isetts, B.J. (2005) Becoming “Indispensable”: Developing Innovative Community Pharmacy Practices. Journal of the American Pharmacists Association, 45, 376-389. http://dx.doi.org/10.1331/1544345054003859
|
[5]
|
Doucette, W.R., Kreling, D.H., Schommer, J.C., Gaither, C.A., Mott, D.A. and Pedersen, C.A. (2006) Evaluation of Community Pharmacy Service Mix: Evidence from the 2004 National Pharmacist Workforce Study. Journal of the American Pharmacists Association, 46, 348-355. http://dx.doi.org/10.1331/154434506777069651
|
[6]
|
Giberson, S., Yoder, S. and Lee, M.P. (2011) Improving Patient and Health System Outcomes through Advanced Pharmacy Practice. A Report to the U.S. Surgeon General. Office of the Chief Pharmacist, U.S. Public Health Service.
|
[7]
|
Ganther, J.M. (2002) Third-Party Reimbursement for Pharmacist Services: Why Has It Been So Difficult to Obtain and Is It Really the Answer for Pharmacy. Journal of the American Pharmacists Association, 42, 875-879. http://dx.doi.org/10.1331/108658002762063736
|
[8]
|
Beatty, S.J., Rodis, J.L., Bellebaum, K.L. and Mehta, B.H. (2006) Community and Ambulatory Pharmacy: Evaluation of Patient Care Services and Billing Patterns before Implementation of Medicare Part D. Journal of the American Pharmacists Association, 46, 707-714. http://dx.doi.org/10.1331/1544-3191.46.6.707.Beatty
|
[9]
|
Beatty, S.J., McCormick, K.M., Beale, D.J., Bruggeman, A.M., Rodis, J.L., Mehta, B.H. and Bennett, M.S. (2012) Current Trends in Outpatient Pharmacy Services and Billing. Journal of the American Pharmacists Association, 52, 154-160. http://dx.doi.org/10.1331/JAPhA.2012.11213
|
[10]
|
Bernsten, C., Andersson, K., Gariepy, Y. and Simoens, S. (2010) A Comparative Analysis of Remuneration Models for Pharmaceutical Professional Services. Health Policy, 95, 1-9. http://dx.doi.org/10.1016/j.healthpol.2009.11.008
|
[11]
|
Skelton, J.B. (2011) Pharmacist-Provided Immunization Compensation and Recognition: White Paper Summarizing APhA/AMCP Stakeholder Meeting. Journal of the American Pharmacists Association, 51, 704-712. http://dx.doi.org/10.1331/JAPhA.2011.11544
|
[12]
|
Federal Register/Vol. 70, No. 18/Friday, January 28, 2005/Rules and Regulations.
|
[13]
|
Snella, K.A., Trewyn, R.R., Hansen, L.B., et al. (2004) Pharmacist Compensation for Cognitive Services: Focus on the Physician Office and Community Pharmacy. Pharmacotherapy, 24, 372-388. http://dx.doi.org/10.1592/phco.24.4.372.33179
|
[14]
|
Schafermeyer, K. (1999) The Impact of Managed Care on Pharmacy Practice. In: Navarro, R., Ed., Managed Care Pharmacy Practice, Aspen Publishers, Gaithersburg, 451-473.
|
[15]
|
Bluml, B.M., McKenney, J.M. and Cziraky, M.J. (2000) Pharmaceutical Care Services and Results in Project Impact: Hyperlipidemia. Journal of the American Pharmacists Association, 40, 157-165.
|
[16]
|
Bennett, M.S., Blank, D., Bopp, J., et al. (2000) Strategies to improve compensation for pharmaceutical care services. Journal of the American Pharmacists Association, 40, 747-755, 870-872.
|
[17]
|
Johannesson, M., Johansson, P.-O. and Jönsson, B. (1992) Economic Evaluation of Drug Therapy: A Review of the Contingent Valuation Method. PharmacoEconomics, 1, 325-337. http://dx.doi.org/10.2165/00019053-199201050-00004
|
[18]
|
Woelfel, J.A., Carr-Lopez, S.M., Delos Santos, M., Bui, A., Patel, R.A., Walberg, M.P. and Galal, S.M. (2014) Assessing Medicare beneficiaries’ Willingness-to-Pay for Medication Therapy Management Services. The Consultant Pharmacist, 29, 104-109. http://dx.doi.org/10.4140/TCP.n.2014.104
|
[19]
|
Schuh, M.J. and Droege, M. (2008) Cognitive Services Provided by Pharmacists: Is the Public Willing to Pay for Them? The Consultant Pharmacist, 23, 223-230. http://dx.doi.org/10.4140/TCP.n.2008.223
|
[20]
|
Friedrich, M., Zgarrick, D., Masood, A. and Montuoro, J. (2010) Patients’ Needs and Interests in a Self-Pay Medication Therapy Management Service. Journal of the American Pharmacists Association, 50, 72-77. http://dx.doi.org/10.1331/JAPhA.2010.08126
|
[21]
|
Blumenschein, K., Johannesson, M. and Yokoyama, K. (2001) Hypothetical vs. Real Willingness to Pay in the Health Sector: Results from a Field Experiment. Journal of Health Economics, 20, 441-457. http://dx.doi.org/10.1016/S0167-6296(01)00075-3
|
[22]
|
Blomquist, G.C., Blumenschein, K. and Johannesson, M. (2009) Eliciting Willingness to Pay without Bias Using Follow-Up Certainty Statements: Comparison between Probably/Definitely and a 10-Point Certainty Scale. Environmental and Resource Economics, 43, 473-502. http://dx.doi.org/10.1007/s10640-008-9242-8
|
[23]
|
Blumenschein, K., Blomquist, G.C., Johannesson, M., Horn, N. and Freeman, P. (2008) Eliciting Willingness to Pay without Bias: Evidence from a Field Experiment. The Economic Journal, 118, 114-137.
|
[24]
|
Carson, R.T. (2000) Contingent Valuation: A User’s Guide. Environmental Science and Technology, 34, 1413-1418. http://dx.doi.org/10.1021/es990728j
|
[25]
|
Wang, J. and Hong, S.H. (2012) Contingent Valuation and Pharmacists’ Acceptable Levels of Compensation for Medication Therapy Management Services. Research in Social & Administrative Pharmacy. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445666/pdf/nihms365450.pdf
|
[26]
|
Global Initiative for Asthma (GINA) (2004) Global Strategy for Asthma Management and Prevention. National Institute of Health, Bethesda, Publication No. 02-3659.
|
[27]
|
Basagaa, X., Sunyer, J., Kogevinas, M., et al. (2004) Socioeconomic Status and Asthma Prevalence in Young Adults. American Journal of Epidemiology, 160, 178-188. http://dx.doi.org/10.1093/aje/kwh186
|
[28]
|
Robbins, J.M., Vaccarino, V., Zhang, H., et al. (2001) Socioeconomic Status and Type 2 Diabetes in African American and Non-Hispanic White Women and Men: Evidence from the Third National Health and Nutrition Examination Survey. American Journal of Public Health, 91, 76-83. http://dx.doi.org/10.2105/AJPH.91.1.76
|
[29]
|
Connolly, V., Unwin, N., Sherriff, P., et al. (2000) Diabetes Prevalence and Socioeconomic Status: A Population Based Study Showing Increased Prevalence of Type 2 Diabetes Mellitus in Deprived Areas. Journal of Epidemiology & Community Health, 54, 173-177. http://dx.doi.org/10.1136/jech.54.3.173
|
[30]
|
Kradjan, W.A., Schulz, R., Christensen, D.B., et al. (1999) Patients’ Perceived Benefit from and Satisfaction with Asthma-Related Pharmacy Services. Journal of the American Pharmacists Association, 39, 658-666.
|
[31]
|
Smith, M., Cannon-Breland, M.L. and Spiggle, S. (2013) Consumer, Physician, and Payer Perspectives on Primary Care Medication Management Services with a Shared Resource Pharmacist Network. Research in Social & Administrative Pharmacy.
|